PO-0742: Image-guided IMRT reduces late toxicity compared to 3D-CRT for prostate cancer. (April 2016) - Wortel, R.; Incrocci, L.; Pos, F.; Van der Heide, U.; Lebesque, J.; Aluwini, S.; Witte, M.; Heemsbergen, W.